Clinical Trials Browser

Completed × tislelizumab × Tumor-Agnostic × Clear all

NCT05516914 2026-04-01

A Phase Ib/II Clinical Trial of LBL-007 Combined With Tislelizumab in the Treatment of Malignant Tumors

Phase 1/2 Completed

Neoplasms

NCT06238752 2024-02-02

RENMIN-213

Phase 2 Completed

Adenocarcinoma